Does short-term smoking cessation reduce plasma total homocysteine concentrations?

S Tonstad1, P Urdal

  • 1Department of Preventive Cardiology, Ullevål Hospital, Oslo, Norway. serena.tonstad@ulleval.no

Insights

Smoking cessation for 10-11 weeks did not significantly lower plasma total homocysteine levels in men and women. This finding suggests that quitting smoking alone may not be sufficient to reduce homocysteine, a risk factor for cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Public Health
  • Biochemistry

Background:

  • Elevated plasma total homocysteine and cigarette smoking are known risk factors for occlusive cardiovascular disease.
  • Understanding the impact of smoking cessation on homocysteine levels is crucial for cardiovascular risk management.

Purpose of the Study:

  • To investigate whether smoking cessation for 10-11 weeks influences plasma total homocysteine concentrations.
  • To assess these effects in individuals with and without established cardiovascular disease.

Main Methods:

  • A study involving men and women with and without cardiovascular disease.
  • Comparison of plasma total homocysteine and HDL cholesterol levels between smoking quitters and persistent smokers.
  • Analysis of baseline homocysteine levels in relation to smoking cessation outcomes.

Main Results:

  • Smoking quitters showed statistically significant higher HDL cholesterol concentrations compared to those who continued smoking.
  • No significant differences in plasma total homocysteine concentrations were observed between quitters and non-quitters.
  • No differences were found even when analyzing subjects with high baseline homocysteine levels.

Conclusions:

  • Smoking cessation for a mean of 10-11 weeks did not lead to a significant reduction in plasma total homocysteine concentrations.
  • While smoking cessation positively impacts HDL cholesterol, it may not be sufficient to lower homocysteine levels on its own.

Related Concept Videos